Loading viewer...
investor_presentation
Format: PDF investor_presentation
CORPORATE PRESENTATION Nasdaq: SPRC February 2022
February 2022This presentation ofSciSparc Ltd.(the“Company”)contains“forward -looking statements ”within the meaning ofthe Private Securities Litigation Reform Actand other
securities laws .Words such as“expects,”“anticipates, ”“intends,”“plans,”“believes,”“seeks,”“estimates ”and similar expressions orvariations ofsuch words areintended
toidentify forward -looking statements .Forexample, theCompany isusing forward -looking statements when itdiscusses statements relating toitsobjectives, plans, and
strategies, the expected timing oftrials, itsproduct pipeline, theresearch, development, and use ofitsplatform technologies, products and product candidates, and all
statements (other than statements ofhistorical facts) that address activities, events, ordevelopments that theCompany intends, expects, projects, believes, oranticipates
will ormay occur inthe future .Forward -looking statements are not historical facts, and are based upon management ’scurrent expectations, beliefs and projections,
many ofwhich, bytheir nature, areinherently uncertain .Such expectations, beliefs and projections areexpressed ingood faith .However, there can benoassurance that
management ’sexpectations, beliefs and projections willbeachieved and actual results may differ materially from what isexpressed inorindicated bytheforward -looking
statements .Forward -looking statements aresubject torisks and uncertainties that could cause actual performance orresults todiffer materially from those expressed in
the forward -looking statements .Foramore detailed description oftherisks and uncertainties affecting theCompany, reference ismade tothe Company’sreports filed
from time totime with theSecurities and Exchange Commission including, butnotlimited to,therisks detailed intheCompany’sannual report onForm 20-Ffortheyear
ended December 31,2020.Forward -looking statements speak only asofthedate thestatements aremade .The Company assumes noobligation toupdate forward -looking
statements toreflect actual results, subsequent events orcircumstances, changes inassumptions orchanges inother factors affecting forward -looking information except to
theextent required byapplicable securities laws .IftheCompany does update one ormore forward -looking statements, noinference should bedrawn that theCompany will
make additional updates with respect thereto orwith respect toother forward -looking statements .SAFE HARBOR STATEMENT
We are revolutionizing cannabinoid -base d
treatments by developing proprietar y pharmaceuticals
that increase patients’safety byreducing doses whil e
maintaining effectiveness
3•Market Cap: $16.3 *
•Shares Outstanding: 3.1M
•Founds raised during the
past 18 months: $17M
*As of February 14, 2022
4•New Leadership since August 2020
•Accelerated R&D activities
•Strengthened IPportfolio: New patents granted
(U.S., Japan and Australia)
•ReceivedTM(Trademark) intheU.S. forCannAmide ,our
proprietary Palmitoylethanolamide formulation, one of
Preview truncated — download the full document for the complete content.
investor_presentation
81 Pages
American International Group